Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Regeneron Pharmaceuticals Inc
F:RGO
Regeneron Pharmaceuticals Inc
F:RGO
Price:
656.8
EUR
-5.74%
Market Closed
Market Cap:
€72.4B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
R
|
Regeneron Pharmaceuticals Inc
F:RGO
|
US |
|
P
|
PARK & Bellheimer AG
F:PKB
|
DE |
|
A
|
Argo Graphene Solutions Corp
CNSX:ARGO
|
CA |
|
W
|
Wyndham Hotels & Resorts Inc
F:2WY
|
US |
|
FDM Group (Holdings) PLC
LSE:FDM
|
UK |
|
Bosch Fren Sistemleri Sanayi ve Ticaret AS
IST:BFREN.E
|
TR |
|
C
|
Coca-Cola Co
F:CCC3
|
US |
|
E
|
Ecolab Inc
XMUN:ECJ
|
US |
|
C
|
Canadian Tire Corporation Ltd
TSX:CTC
|
CA |
|
CNMC Goldmine Holdings Ltd
SGX:5TP
|
SG |
|
U
|
United Internet AG
XMUN:UTDI
|
DE |
|
R
|
Realty Income Corp
XMUN:RY6
|
US |
|
Orange SA
F:FTE
|
FR |
|
China Shenhua Energy Co Ltd
F:IKF
|
CN |
|
I
|
Illumina Inc
DUS:ILU
|
US |
|
S
|
Shopify Inc
F:307
|
CA |
Wall St Price Targets
RGO Price Forecast
Based on 34 analysts
Based on 34 analysts
+15% Upside
from
€656.8
today
Regeneron Pharmaceuticals Inc (RGO)’s 12-month stock price forecast through September 2027 has a consensus target of €756.29, implying 15% upside. The forecast is based on price targets from 34 Wall Street analysts.
RGO Analyst Rating
No ratings yet
No ratings yet
Regeneron Pharmaceuticals Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is RGO's stock price target?
Price Target
756.29
EUR
756.29
EUR
According to Wall Street analysts, the average 1-year price target for RGO is 756.29 EUR with a low forecast of 581.48 EUR and a high forecast of 943.4 EUR.
What is the Revenue forecast for Regeneron Pharmaceuticals Inc?
Projected CAGR
5%
5%
Over the last 13 years, the compound annual growth rate for Revenue has been 20%. The projected CAGR for the next 8 years is 5%.
What is the Gross Profit forecast for Regeneron Pharmaceuticals Inc?
Projected CAGR
5%
5%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 19%. The projected CAGR for the next 8 years is 5%.
What is the Operating Income forecast for Regeneron Pharmaceuticals Inc?
Projected CAGR
11%
11%
Over the last 13 years, the compound annual growth rate for Operating Income has been 18%. The projected CAGR for the next 8 years is 11%.
What is the Pre-Tax Income forecast for Regeneron Pharmaceuticals Inc?
Projected CAGR
18%
18%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 22%. The projected CAGR for the next 3 years is 18%.
What is the Net Income forecast for Regeneron Pharmaceuticals Inc?
Projected CAGR
8%
8%
Over the last 13 years, the compound annual growth rate for Net Income has been 15%. The projected CAGR for the next 8 years is 8%.